ATB Therapeutics
PrivateLast Round
Series A
Nov 18, 2024
Total Funding Raised
$62.6M
Momentum Score
25 /100
Company Overview
ATB Therapeutics is a biotechnology company that develops a new class of antibody-based targeted therapies, called atbodies, to treat cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine, Clean Manufacturing
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ATB Therapeutics Comps
Public and private peers based on sector, stage, and business model.
ATB Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 18, 2024 | ||||
| Seed | Dec 23, 2019 | ||||
| Seed | Jan 1, 2018 |
Key People
Founding team and executive leadership
ATB Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Federal Holding and Investment Company | Series A |
| MRL Ventures Fund | Series A |
| EQT Life Sciences | Series A |
| Noshaq | Seed |
| Wallonie Entreprendre | Series A |
| V-Bio Ventures | Series A |
| VIVES Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 18, 2024
Raised $57M in Series A funding.
ATB Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ATB Therapeutics's valuation, stock price, and market status.
